This action requires you to be registered with Frontiers and logged in. To register or login click here.
Please indicate why this content is being reported:
Your message has been sent to the Frontiers Administration Office and will be dealt with as soon as possible.
Contributors/Organisations: Elsevier
Science > Neuroscience > Alzheimer's Disease
Science > Neuroscience > Behavioral Neuroscience Archive
Science > Neuroscience > Brain Imaging Methods
Science > Pharmacology > Clinical Trials and Pharmacotherapy
Science > Drug Development > Biopharmaceuticals
Health > Neurology > Alzheimer's Disease
Health > Neurology > Clinical Trials in Neurology
Health > Neurology > Ageing
Health > Neurology > Brain Imaging Methods
Health > Psychiatry > Addictive Disorders
Health > Psychiatry > Mood Disorders
Health > Psychiatry > Alzheimer's Disease
Health > Psychiatry > Anxiety, Stress, and Obsessional Disorders
Health > Psychiatry > Ageing
Health > Psychiatry > Psychopharmacology
Health > Psychiatry > Psychotic Disorders
Health > Psychiatry > Schizophrenia
Keywords: Drug discovery and development, Drug Development
Posted by: Robert Albert McArthur
Posted on: 17 Jan 2013
You are in
Alzheimer's Disease
OHBM Neuroimaging in Psychiatry - Part II
Andreas Meyer-Lindenberg
In vivo screening for anti=psychotic drugs using zebrafish
JUSTIN DAVID CLIFTON
Javascript is disabled. Please enable Javascript in your browser settings in order to see all the content on this page.